Loading…
The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial
Tart Montmorency cherries (MC) have been shown to be rich in anthocyanins and other phytochemicals known to have anti-inflammatory properties and influence pathways that might improve cardiometabolic health. However, there is limited evidence for the longer-term use of tart cherries on these indices...
Saved in:
Published in: | Nutrients 2021-04, Vol.13 (5), p.1417 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63 |
---|---|
cites | cdi_FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63 |
container_end_page | |
container_issue | 5 |
container_start_page | 1417 |
container_title | Nutrients |
container_volume | 13 |
creator | Kimble, Rachel Keane, Karen M Lodge, John K Howatson, Glyn |
description | Tart Montmorency cherries (MC) have been shown to be rich in anthocyanins and other phytochemicals known to have anti-inflammatory properties and influence pathways that might improve cardiometabolic health. However, there is limited evidence for the longer-term use of tart cherries on these indices. The aim of the current study was to investigate the influence of MC concentrate on cardiometabolic health indices following a 3-month supplementation period.
Fifty middle-aged adults (34 males and 16 females; mean ± SD age: 48 ± 6 years and BMI: 27.6 ± 3.7 kg/m
) completed a randomised, placebo-controlled parallel study in which they either received MC or an isocaloric placebo. Participants drank 30 mL of their allocated treatment twice per day for 3 months. Vascular function (blood pressure [BP], heart rate [HR], pulse wave velocity and analysis [PWV/A], and flow mediated dilation [FMD]) as well as indices of metabolic health (insulin, glucose, lipid profiles, and high sensitivity C reactive protein) were measured following an overnight fast before and after the 3 months.
No effect of the intervention between the groups was observed for vascular function or metabolic health variables following the intervention (
> 0.05). However, MC concentrate was shown to be safe and well-tolerated and, importantly, did not have any deleterious effects on these outcomes. In conclusion, MC has no influence on cardiometabolic indices in middle-aged adults. |
doi_str_mv | 10.3390/nu13051417 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_449ddcd4428044cba0b1062c56401e01</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A765866800</galeid><doaj_id>oai_doaj_org_article_449ddcd4428044cba0b1062c56401e01</doaj_id><sourcerecordid>A765866800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63</originalsourceid><addsrcrecordid>eNptks1u1DAQxyMEolXphQdAlrgAaoq_4iQckFYrCiu1oirL2XLsya4Xx17spFIfkPfC7Za2K2Ef7LF_8_fMeIriNcGnjLX4o58IwxXhpH5WHFJc01IIzp4_2R8Uxylt8O2ocS3Yy-Ige1LKW3ZY_FmuAS187ybwGlDo0VLFEc3XEOMNeocu4-SnhDRElaZ0gvQ1ugh-HELM_M17NA_ZzY9RjYB-TNutgyGbarTBoz5ExO7wdULZnqtobBhgVF1wVqMrm36hM6XHEBOyHl1YYxyUsxUYNDOTG9MnNENXypsw2ATmBF06paELZX51jMG5DC6jVe5V8aJXLsHx_XpU_Dz7spx_K8-_f13MZ-elrlg7lh1Rne4IEEJwzWjV0BaY6KqamIZQqBnoVpsWGgU95kowTlpTGaZaAcC0YEfFYqdrgtrIbbSDijcyKCvvDkJcyVw9qx1IzltjtOGcNphz3SncESyorgTHBDDJWp93WtupG8Dsquj2RPdvvF3LVbiWDeFV_sYs8PZeIIbfE6RRbsIUfc5f0opRUlctJ4_USuWorO9DFtO5nlrOalE1QjQYZ-r0P1SeBgarg4fe5vM9hw87Bx1DShH6h8AJlreNKR8bM8Nvnqb6gP5rQ_YXx8feaQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2532175941</pqid></control><display><type>article</type><title>The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Kimble, Rachel ; Keane, Karen M ; Lodge, John K ; Howatson, Glyn</creator><creatorcontrib>Kimble, Rachel ; Keane, Karen M ; Lodge, John K ; Howatson, Glyn</creatorcontrib><description>Tart Montmorency cherries (MC) have been shown to be rich in anthocyanins and other phytochemicals known to have anti-inflammatory properties and influence pathways that might improve cardiometabolic health. However, there is limited evidence for the longer-term use of tart cherries on these indices. The aim of the current study was to investigate the influence of MC concentrate on cardiometabolic health indices following a 3-month supplementation period.
Fifty middle-aged adults (34 males and 16 females; mean ± SD age: 48 ± 6 years and BMI: 27.6 ± 3.7 kg/m
) completed a randomised, placebo-controlled parallel study in which they either received MC or an isocaloric placebo. Participants drank 30 mL of their allocated treatment twice per day for 3 months. Vascular function (blood pressure [BP], heart rate [HR], pulse wave velocity and analysis [PWV/A], and flow mediated dilation [FMD]) as well as indices of metabolic health (insulin, glucose, lipid profiles, and high sensitivity C reactive protein) were measured following an overnight fast before and after the 3 months.
No effect of the intervention between the groups was observed for vascular function or metabolic health variables following the intervention (
> 0.05). However, MC concentrate was shown to be safe and well-tolerated and, importantly, did not have any deleterious effects on these outcomes. In conclusion, MC has no influence on cardiometabolic indices in middle-aged adults.</description><identifier>ISSN: 2072-6643</identifier><identifier>EISSN: 2072-6643</identifier><identifier>DOI: 10.3390/nu13051417</identifier><identifier>PMID: 33922493</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adults ; Anthocyanins ; Anti-inflammatory agents ; Antioxidants ; Blood pressure ; C-reactive protein ; cardiovascular disease ; Cherries ; Clinical trials ; Diabetes ; Dietary supplements ; Disease ; Exercise ; Fruits ; Health risks ; Heart beat ; Heart rate ; Hormone replacement therapy ; Hypertension ; Inflammation ; Insulin ; Lipids ; metabolic health ; Metabolism ; Metabolites ; Middle age ; Mortality ; Nitric oxide ; Physical fitness ; Placebos ; Prunus cerasus ; Questionnaires ; Risk analysis ; Risk factors ; tart cherry ; Type 2 diabetes ; vascular function ; Wave velocity</subject><ispartof>Nutrients, 2021-04, Vol.13 (5), p.1417</ispartof><rights>COPYRIGHT 2021 MDPI AG</rights><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63</citedby><cites>FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63</cites><orcidid>0000-0001-8494-2043 ; 0000-0002-1572-9211</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2532175941/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2532175941?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33922493$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kimble, Rachel</creatorcontrib><creatorcontrib>Keane, Karen M</creatorcontrib><creatorcontrib>Lodge, John K</creatorcontrib><creatorcontrib>Howatson, Glyn</creatorcontrib><title>The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial</title><title>Nutrients</title><addtitle>Nutrients</addtitle><description>Tart Montmorency cherries (MC) have been shown to be rich in anthocyanins and other phytochemicals known to have anti-inflammatory properties and influence pathways that might improve cardiometabolic health. However, there is limited evidence for the longer-term use of tart cherries on these indices. The aim of the current study was to investigate the influence of MC concentrate on cardiometabolic health indices following a 3-month supplementation period.
Fifty middle-aged adults (34 males and 16 females; mean ± SD age: 48 ± 6 years and BMI: 27.6 ± 3.7 kg/m
) completed a randomised, placebo-controlled parallel study in which they either received MC or an isocaloric placebo. Participants drank 30 mL of their allocated treatment twice per day for 3 months. Vascular function (blood pressure [BP], heart rate [HR], pulse wave velocity and analysis [PWV/A], and flow mediated dilation [FMD]) as well as indices of metabolic health (insulin, glucose, lipid profiles, and high sensitivity C reactive protein) were measured following an overnight fast before and after the 3 months.
No effect of the intervention between the groups was observed for vascular function or metabolic health variables following the intervention (
> 0.05). However, MC concentrate was shown to be safe and well-tolerated and, importantly, did not have any deleterious effects on these outcomes. In conclusion, MC has no influence on cardiometabolic indices in middle-aged adults.</description><subject>Adults</subject><subject>Anthocyanins</subject><subject>Anti-inflammatory agents</subject><subject>Antioxidants</subject><subject>Blood pressure</subject><subject>C-reactive protein</subject><subject>cardiovascular disease</subject><subject>Cherries</subject><subject>Clinical trials</subject><subject>Diabetes</subject><subject>Dietary supplements</subject><subject>Disease</subject><subject>Exercise</subject><subject>Fruits</subject><subject>Health risks</subject><subject>Heart beat</subject><subject>Heart rate</subject><subject>Hormone replacement therapy</subject><subject>Hypertension</subject><subject>Inflammation</subject><subject>Insulin</subject><subject>Lipids</subject><subject>metabolic health</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Middle age</subject><subject>Mortality</subject><subject>Nitric oxide</subject><subject>Physical fitness</subject><subject>Placebos</subject><subject>Prunus cerasus</subject><subject>Questionnaires</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>tart cherry</subject><subject>Type 2 diabetes</subject><subject>vascular function</subject><subject>Wave velocity</subject><issn>2072-6643</issn><issn>2072-6643</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks1u1DAQxyMEolXphQdAlrgAaoq_4iQckFYrCiu1oirL2XLsya4Xx17spFIfkPfC7Za2K2Ef7LF_8_fMeIriNcGnjLX4o58IwxXhpH5WHFJc01IIzp4_2R8Uxylt8O2ocS3Yy-Ige1LKW3ZY_FmuAS187ybwGlDo0VLFEc3XEOMNeocu4-SnhDRElaZ0gvQ1ugh-HELM_M17NA_ZzY9RjYB-TNutgyGbarTBoz5ExO7wdULZnqtobBhgVF1wVqMrm36hM6XHEBOyHl1YYxyUsxUYNDOTG9MnNENXypsw2ATmBF06paELZX51jMG5DC6jVe5V8aJXLsHx_XpU_Dz7spx_K8-_f13MZ-elrlg7lh1Rne4IEEJwzWjV0BaY6KqamIZQqBnoVpsWGgU95kowTlpTGaZaAcC0YEfFYqdrgtrIbbSDijcyKCvvDkJcyVw9qx1IzltjtOGcNphz3SncESyorgTHBDDJWp93WtupG8Dsquj2RPdvvF3LVbiWDeFV_sYs8PZeIIbfE6RRbsIUfc5f0opRUlctJ4_USuWorO9DFtO5nlrOalE1QjQYZ-r0P1SeBgarg4fe5vM9hw87Bx1DShH6h8AJlreNKR8bM8Nvnqb6gP5rQ_YXx8feaQ</recordid><startdate>20210423</startdate><enddate>20210423</enddate><creator>Kimble, Rachel</creator><creator>Keane, Karen M</creator><creator>Lodge, John K</creator><creator>Howatson, Glyn</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8494-2043</orcidid><orcidid>https://orcid.org/0000-0002-1572-9211</orcidid></search><sort><creationdate>20210423</creationdate><title>The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial</title><author>Kimble, Rachel ; Keane, Karen M ; Lodge, John K ; Howatson, Glyn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adults</topic><topic>Anthocyanins</topic><topic>Anti-inflammatory agents</topic><topic>Antioxidants</topic><topic>Blood pressure</topic><topic>C-reactive protein</topic><topic>cardiovascular disease</topic><topic>Cherries</topic><topic>Clinical trials</topic><topic>Diabetes</topic><topic>Dietary supplements</topic><topic>Disease</topic><topic>Exercise</topic><topic>Fruits</topic><topic>Health risks</topic><topic>Heart beat</topic><topic>Heart rate</topic><topic>Hormone replacement therapy</topic><topic>Hypertension</topic><topic>Inflammation</topic><topic>Insulin</topic><topic>Lipids</topic><topic>metabolic health</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Middle age</topic><topic>Mortality</topic><topic>Nitric oxide</topic><topic>Physical fitness</topic><topic>Placebos</topic><topic>Prunus cerasus</topic><topic>Questionnaires</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>tart cherry</topic><topic>Type 2 diabetes</topic><topic>vascular function</topic><topic>Wave velocity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kimble, Rachel</creatorcontrib><creatorcontrib>Keane, Karen M</creatorcontrib><creatorcontrib>Lodge, John K</creatorcontrib><creatorcontrib>Howatson, Glyn</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Nutrients</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kimble, Rachel</au><au>Keane, Karen M</au><au>Lodge, John K</au><au>Howatson, Glyn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial</atitle><jtitle>Nutrients</jtitle><addtitle>Nutrients</addtitle><date>2021-04-23</date><risdate>2021</risdate><volume>13</volume><issue>5</issue><spage>1417</spage><pages>1417-</pages><issn>2072-6643</issn><eissn>2072-6643</eissn><abstract>Tart Montmorency cherries (MC) have been shown to be rich in anthocyanins and other phytochemicals known to have anti-inflammatory properties and influence pathways that might improve cardiometabolic health. However, there is limited evidence for the longer-term use of tart cherries on these indices. The aim of the current study was to investigate the influence of MC concentrate on cardiometabolic health indices following a 3-month supplementation period.
Fifty middle-aged adults (34 males and 16 females; mean ± SD age: 48 ± 6 years and BMI: 27.6 ± 3.7 kg/m
) completed a randomised, placebo-controlled parallel study in which they either received MC or an isocaloric placebo. Participants drank 30 mL of their allocated treatment twice per day for 3 months. Vascular function (blood pressure [BP], heart rate [HR], pulse wave velocity and analysis [PWV/A], and flow mediated dilation [FMD]) as well as indices of metabolic health (insulin, glucose, lipid profiles, and high sensitivity C reactive protein) were measured following an overnight fast before and after the 3 months.
No effect of the intervention between the groups was observed for vascular function or metabolic health variables following the intervention (
> 0.05). However, MC concentrate was shown to be safe and well-tolerated and, importantly, did not have any deleterious effects on these outcomes. In conclusion, MC has no influence on cardiometabolic indices in middle-aged adults.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33922493</pmid><doi>10.3390/nu13051417</doi><orcidid>https://orcid.org/0000-0001-8494-2043</orcidid><orcidid>https://orcid.org/0000-0002-1572-9211</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6643 |
ispartof | Nutrients, 2021-04, Vol.13 (5), p.1417 |
issn | 2072-6643 2072-6643 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_449ddcd4428044cba0b1062c56401e01 |
source | Publicly Available Content Database; PubMed Central |
subjects | Adults Anthocyanins Anti-inflammatory agents Antioxidants Blood pressure C-reactive protein cardiovascular disease Cherries Clinical trials Diabetes Dietary supplements Disease Exercise Fruits Health risks Heart beat Heart rate Hormone replacement therapy Hypertension Inflammation Insulin Lipids metabolic health Metabolism Metabolites Middle age Mortality Nitric oxide Physical fitness Placebos Prunus cerasus Questionnaires Risk analysis Risk factors tart cherry Type 2 diabetes vascular function Wave velocity |
title | The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A40%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Influence%20of%20Tart%20Cherry%20(%20Prunus%20cerasus,%20cv%20Montmorency)%20Concentrate%20Supplementation%20for%203%20Months%20on%20Cardiometabolic%20Risk%20Factors%20in%20Middle-Aged%20Adults:%20A%20Randomised,%20Placebo-Controlled%20Trial&rft.jtitle=Nutrients&rft.au=Kimble,%20Rachel&rft.date=2021-04-23&rft.volume=13&rft.issue=5&rft.spage=1417&rft.pages=1417-&rft.issn=2072-6643&rft.eissn=2072-6643&rft_id=info:doi/10.3390/nu13051417&rft_dat=%3Cgale_doaj_%3EA765866800%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2532175941&rft_id=info:pmid/33922493&rft_galeid=A765866800&rfr_iscdi=true |